Sun Pharmaceutical Industries Limited (BOM:524715)
1,670.85
+12.50 (0.75%)
At close: Oct 10, 2025
BOM:524715 Revenue
Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.45
Revenue / Employee
12.51M
Employees
43,000
Market Cap
4,009.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,585.24B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Bajaj Finance | 387.76B |
Infosys | 1,672.76B |
Sun Pharmaceutical Industries News
- 1 day ago - Stocks to Watch Today, October 9: HFCL, Coal India, Prestige Estates, GR Infra, Lupin, Senco Gold, Saatvik Green, Adani Power, Sun Pharma in focus - Business Upturn
- 9 days ago - Sun Pharma shares rally nearly 3% as Citi reiterates ‘Buy’ rating, says pricing overhangs now resolved after Pfizer deal - Business Upturn
- 9 days ago - [Brokerage Calls] Stocks to watch on October 1: Ultratech Cement, Muthoot Finance, Manappuram Finance, Amber, Syrma SGS, Sun Pharma and more - Business Upturn
- 9 days ago - Citi bullish on Sun Pharma shares, says MFN and pricing overhangs now resolved after Pfizer deal - Business Upturn
- 9 days ago - Stock Market Live Updates Today, October 1: Adani Enterprises, Power Grid, Adani Green, L&T Technology in focus - Business Upturn
- 9 days ago - Top stocks to watch today, October 1: Adani Enterprises, Sun Pharma, L&T Technology, Adani Green and more - Business Upturn
- 13 days ago - Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained - The Times of India
- 13 days ago - Not a med emergency: Generic pharma cos spared from harm - The Times of India